Ontology highlight
ABSTRACT:
SUBMITTER: Socola F
PROVIDER: S-EPMC4928356 | biostudies-other | 2013
REPOSITORIES: biostudies-other
ImmunoTargets and therapy 20130918
Non-small cell lung cancer (NSCLC) unfortunately carries a very poor prognosis. Patients usually do not become symptomatic, and therefore do not seek treatment, until the cancer is advanced and it is too late to employ curative treatment options. New therapeutic options are urgently needed for NSCLC, because even current targeted therapies cure very few patients. Active immunotherapy is an option that is gaining more attention. A delicate and complex interplay exists between the tumor and the im ...[more]